Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aptech Ltd. Regulatory Filings 2021

Feb 8, 2021

60838_rns_2021-02-08_72012559-c4cc-4cd5-ad3b-9617b3fd17d3.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Aptech Limited Regd. office: Aptech House A-65, MIDC, Moroi, Andheri (E), Mumbai - 400 093. T: 91 22 2827 2300 F: 91 22 2827 2399 www aptech-worldwide corn

==> picture [202 x 56] intentionally omitted <==

Unleash your potential

8[th] February, 2021

To, BSE Limited 25[th] Floor, P J Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532475

To, National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051. Symbol: APTECHT

Dear Sir/Madam,

Sub: Intimation of schedule of Analyst Meet under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015

We have to inform you that Aptech Limited representatives will participate in analyst/ investor meetings as per the schedule given below:

Date Company Name Venue
8thFebruary, 2021 Lacuna Vermogen Telephone call

The quarterly results to be discussed at the event have been uploaded on the website at - https://www.aptech worldwide.com/downloads/investorrelations_financials/ConsolDecember2020.pdf

This is for your information and record.

Thanking you,

Yours faithfully,

For Aptech Limited

==> picture [65 x 48] intentionally omitted <==

Jagruti Shah Company Secretary & Compliance Officer Membership no.: F10909 Place: Mumbai

==> picture [280 x 15] intentionally omitted <==